BioCentury
ARTICLE | Company News

VC tracks

October 18, 2014 2:34 AM UTC

Canaan Partners promoted Tim Shannon to general partner and Julie Papanek to principal on the healthcare team. Shannon joined Canaan in 2009 after serving as CEO of CuraGen Corp. through its sale to Celldex Therapeutics Inc. (NASDAQ:CLDX). Shannon remains a director at Celldex, holds board seats at Canaan portfolio companies Aldea Pharmaceuticals Inc. (Redwood City, Calif.); Civitas Therpeutics Inc. (Chelsea, Mass.); CytomX Therapeutics Inc. (South San Francisco, Calif.); and Novira Therapeutics Inc. (Radnor, Pa.). Prior to joining Canaan as an associate in August 2013, Papanek worked in marketing, development, and business development at Genentech. ...